Fibrogenic potential of human multipotent mesenchymal stromal cells in injured liver. 2009

Reto M Baertschiger, and Véronique Serre-Beinier, and Philippe Morel, and Domenico Bosco, and Marion Peyrou, and Sophie Clément, and Antonino Sgroi, and André Kaelin, and Leo H Buhler, and Carmen Gonelle-Gispert
Surgical Research Unit, Department of Surgery, University Hospital Geneva, Geneva, Switzerland.

Multipotent mesenchymal stromal cells (MSC) are currently investigated clinically as cellular therapy for a variety of diseases. Differentiation of MSC toward endodermal lineages, including hepatocytes and their therapeutic effect on fibrosis has been described but remains controversial. Recent evidence attributed a fibrotic potential to MSC. As differentiation potential might be dependent of donor age, we studied MSC derived from adult and pediatric human bone marrow and their potential to differentiate into hepatocytes or myofibroblasts in vitro and in vivo. Following characterization, expanded adult and pediatric MSC were co-cultured with a human hepatoma cell line, Huh-7, in a hepatogenic differentiation medium containing Hepatocyte growth factor, Fibroblast growth factor 4 and oncostatin M. In vivo, MSC were transplanted into spleen or liver of NOD/SCID mice undergoing partial hepatectomy and retrorsine treatment. Expression of mesenchymal and hepatic markers was analyzed by RT-PCR, Western blot and immunohistochemistry. In vitro, adult and pediatric MSC expressed characteristic surface antigens of MSC. Expansion capacity of pediatric MSC was significantly higher when compared to adult MSC. In co-culture with Huh-7 cells in hepatogenic differentiation medium, albumin expression was more frequently detected in pediatric MSC (5/8 experiments) when compared to adult MSC (2/10 experiments). However, in such condition pediatric MSC expressed alpha smooth muscle more strongly than adult MSC. Stable engraftment in the liver was not achieved after intrasplenic injection of pediatric or adult MSC. After intrahepatic injection, MSC permanently remained in liver tissue, kept a mesenchymal morphology and expressed vimentin and alpha smooth muscle actin, but no hepatic markers. Further, MSC localization merges with collagen deposition in transplanted liver and no difference was observed using adult or pediatric MSC. In conclusion, when transplanted into an injured or regenerating liver, MSC differentiated into myofibroblasts with development of fibrous tissue, regardless of donor age. These results indicate that MSC in certain circumstances might be harmful due to their fibrogenic potential and this should be considered before potential use of MSC for cell therapy.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008648 Mesoderm The middle germ layer of an embryo derived from three paired mesenchymal aggregates along the neural tube. Mesenchyme,Dorsal Mesoderm,Intermediate Mesoderm,Lateral Plate Mesoderm,Mesenchyma,Paraxial Mesoderm,Dorsal Mesoderms,Intermediate Mesoderms,Lateral Plate Mesoderms,Mesenchymas,Mesoderm, Dorsal,Mesoderm, Intermediate,Mesoderm, Lateral Plate,Mesoderm, Paraxial,Mesoderms, Dorsal,Mesoderms, Intermediate,Mesoderms, Lateral Plate,Mesoderms, Paraxial,Paraxial Mesoderms,Plate Mesoderm, Lateral,Plate Mesoderms, Lateral
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000199 Actins Filamentous proteins that are the main constituent of the thin filaments of muscle fibers. The filaments (known also as filamentous or F-actin) can be dissociated into their globular subunits; each subunit is composed of a single polypeptide 375 amino acids long. This is known as globular or G-actin. In conjunction with MYOSINS, actin is responsible for the contraction and relaxation of muscle. F-Actin,G-Actin,Actin,Isoactin,N-Actin,alpha-Actin,alpha-Isoactin,beta-Actin,gamma-Actin,F Actin,G Actin,N Actin,alpha Actin,alpha Isoactin,beta Actin,gamma Actin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings

Related Publications

Reto M Baertschiger, and Véronique Serre-Beinier, and Philippe Morel, and Domenico Bosco, and Marion Peyrou, and Sophie Clément, and Antonino Sgroi, and André Kaelin, and Leo H Buhler, and Carmen Gonelle-Gispert
February 2012, Bulletin of experimental biology and medicine,
Reto M Baertschiger, and Véronique Serre-Beinier, and Philippe Morel, and Domenico Bosco, and Marion Peyrou, and Sophie Clément, and Antonino Sgroi, and André Kaelin, and Leo H Buhler, and Carmen Gonelle-Gispert
October 2013, Ultrastructural pathology,
Reto M Baertschiger, and Véronique Serre-Beinier, and Philippe Morel, and Domenico Bosco, and Marion Peyrou, and Sophie Clément, and Antonino Sgroi, and André Kaelin, and Leo H Buhler, and Carmen Gonelle-Gispert
January 2011, Methods in molecular biology (Clifton, N.J.),
Reto M Baertschiger, and Véronique Serre-Beinier, and Philippe Morel, and Domenico Bosco, and Marion Peyrou, and Sophie Clément, and Antonino Sgroi, and André Kaelin, and Leo H Buhler, and Carmen Gonelle-Gispert
January 2007, Bulletin of experimental biology and medicine,
Reto M Baertschiger, and Véronique Serre-Beinier, and Philippe Morel, and Domenico Bosco, and Marion Peyrou, and Sophie Clément, and Antonino Sgroi, and André Kaelin, and Leo H Buhler, and Carmen Gonelle-Gispert
October 2012, Experimental hematology,
Reto M Baertschiger, and Véronique Serre-Beinier, and Philippe Morel, and Domenico Bosco, and Marion Peyrou, and Sophie Clément, and Antonino Sgroi, and André Kaelin, and Leo H Buhler, and Carmen Gonelle-Gispert
June 2014, Medical hypotheses,
Reto M Baertschiger, and Véronique Serre-Beinier, and Philippe Morel, and Domenico Bosco, and Marion Peyrou, and Sophie Clément, and Antonino Sgroi, and André Kaelin, and Leo H Buhler, and Carmen Gonelle-Gispert
May 2013, Bulletin of experimental biology and medicine,
Reto M Baertschiger, and Véronique Serre-Beinier, and Philippe Morel, and Domenico Bosco, and Marion Peyrou, and Sophie Clément, and Antonino Sgroi, and André Kaelin, and Leo H Buhler, and Carmen Gonelle-Gispert
December 2022, Clinical and translational medicine,
Reto M Baertschiger, and Véronique Serre-Beinier, and Philippe Morel, and Domenico Bosco, and Marion Peyrou, and Sophie Clément, and Antonino Sgroi, and André Kaelin, and Leo H Buhler, and Carmen Gonelle-Gispert
July 2007, Transplantation,
Reto M Baertschiger, and Véronique Serre-Beinier, and Philippe Morel, and Domenico Bosco, and Marion Peyrou, and Sophie Clément, and Antonino Sgroi, and André Kaelin, and Leo H Buhler, and Carmen Gonelle-Gispert
July 2018, Digestive diseases and sciences,
Copied contents to your clipboard!